⌘K
Loading ticker…
As of 2026-08-24, Quest Diagnostics Inc. (DGX) has a 3-month relative strength percentile of 85 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 1.9%, relative volume 0.97×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
DGX is in a stage 2 uptrend, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 10.8% / 22.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
DGX is held by 69 ETFs as of May 2026. Top owner: VHT at 0.34% weight, $65M notional. Top 3 carry $130M.
Held by 251 ETFs · $4.2B across latest filings · largest weight 5.31% (SASS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.34% | $65M | — |
| QLTY | 0.85% | $38M | −0.13 pp |
| GSLC | 0.17% | $27M | −0.03 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.03% | $23M | — |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.06% |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| $15M |
| −0.01 pp |
| VONVVanguard Russell 1000 Value ETF | 0.06% | $14M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.03% | $13M | — |
| SCHVSchwab U.S. Large-Cap Value ETF | 0.07% | $11M | — |
| ACWV | 0.18% | $6M | — |
| VOOV | 0.07% | $5M | — |
Showing 10 of 69 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DGX Jan avg: 0.99% median: 1.35% win: 50% σ: 8.07% n: 4 2022-04-12 → 2026-07-31 | DGX Feb avg: 2.44% median: 1.63% win: 50% σ: 9.01% n: 4 2022-04-12 → 2026-07-31 | DGX Mar avg: -0.21% median: 0.06% win: 50% σ: 6.04% n: 4 2022-04-12 → 2026-07-31 | DGX Apr avg: 0.75% median: -0.91% win: 40% σ: 3.58% n: 5 2022-04-12 → 2026-07-31 | DGX May avg: 0.26% median: 0.36% win: 60% σ: 3.98% n: 5 2022-04-12 → 2026-07-31 | DGX Jun avg: 1.81% median: 3.63% win: 60% σ: 6.21% n: 5 2022-04-12 → 2026-07-31 | DGX Jul avg: 1.20% median: 2.70% win: 60% σ: 6.62% n: 5 2022-04-12 → 2026-07-31 | DGX Aug avg: 1.96% median: 2.88% win: 50% σ: 8.92% n: 4 2022-04-12 → 2026-07-31 (current) | DGX Sep avg: -1.40% median: -1.59% win: 25% σ: 5.02% n: 4 2022-04-12 → 2026-07-31 | DGX Oct avg: 3.98% median: 3.25% win: 50% σ: 10.54% n: 4 2022-04-12 → 2026-07-31 | DGX Nov avg: 5.94% median: 5.59% win: 100% σ: 1.09% n: 4 2022-04-12 → 2026-07-31 | DGX Dec avg: -3.00% median: -3.39% win: 50% σ: 5.61% n: 4 2022-04-12 → 2026-07-31 |